Dow Up 0.20% Nasdaq Up 0.31%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM
0.71 Down 0.03(3.50%) 11:25AM EDT - Nasdaq Real Time Price
Prev Close:0.74
Open:0.71
Bid:0.71 x 100
Ask:0.74 x 200
1y Target Est:2.00
Beta:1.69
Next Earnings Date:N/A
Day's Range:0.69 - 0.74
52wk Range:0.39 - 4.91
Volume:32,957
Avg Vol (3m):101,577
Market Cap:9.05M
P/E (ttm):N/A
EPS (ttm):-1.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECTE

Comparison

Symbol% ChgMkt Cap
ECTEDown 3.50%9.05M
ABTDown 0.33%63.53B
DXCMDown 2.22%3.25B
MDTUp 0.49%63.96B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):453.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.19
Quarterly EPS Est (Sep-14) :-0.31
Mean Recommendation*:5.0
PEG Ratio (5 yr expected):-0.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback